1.45 USD
-0.06
3.97%
At close Jun 13, 4:00 PM EDT
After hours
1.41
-0.04
2.76%
1 day
-3.97%
5 days
-5.23%
1 month
-3.33%
3 months
-49.48%
6 months
-66.20%
Year to date
-66.20%
1 year
-50.85%
5 years
-85.92%
10 years
-85.92%
 

About: DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

Employees: 4,407

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

18% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 40

5% more funds holding

Funds holding: 128 [Q4 2024] → 135 (+7) [Q1 2025]

2.86% more ownership

Funds ownership: 54.08% [Q4 2024] → 56.94% (+2.86%) [Q1 2025]

25% less funds holding in top 10

Funds holding in top 10: 4 [Q4 2024] → 3 (-1) [Q1 2025]

35% less capital invested

Capital invested by funds: $234M [Q4 2024] → $153M (-$81M) [Q1 2025]

69% less call options, than puts

Call options by funds: $74K | Put options by funds: $240K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$1.45
0%
upside
Avg. target
$2.23
53%
upside
High target
$3
107%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
Canaccord Genuity
Richard Close
0%upside
$1.45
Hold
Downgraded
12 May 2025
Needham
Ryan MacDonald
107%upside
$3
Buy
Maintained
9 May 2025

Financial journalist opinion

Based on 4 articles about DCGO published over the past 30 days

Neutral
Business Wire
1 week ago
DocGo Announces Upcoming Participation at the Goldman Sachs 46th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th from 4:00 – 4:35 PM Eastern Time, and hold 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at ht.
DocGo Announces Upcoming Participation at the Goldman Sachs 46th Annual Global Healthcare Conference
Neutral
GlobeNewsWire
2 weeks ago
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders.
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
Neutral
PRNewsWire
2 weeks ago
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
NEW YORK , May 29, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives were insufficient for thoroughly examining and verifying the professional and educational backgrounds of applicants; (ii) this inadequacy heightened the risk of disruptive changes in executive leadership; (iii) contrary to what it had communicated to investors, DocGo had overestimated the effectiveness of its mobile health and medical transportation services, which were key components of the Relocation Contract; (iv) all these issues, once disclosed, were likely to expose DocGo to considerable reputational and/or regulatory examination, adversely affecting the company's financial health and future outlook; and (v) consequently, the company's public declarations were inaccurate and misleading throughout the times in question.
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
Neutral
Business Wire
3 weeks ago
DocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards Program
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the “Compliance Management Innovation Award” in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. DocGo's brea.
DocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards Program
Neutral
Seeking Alpha
1 month ago
DocGo, Inc (DCGO) Q1 2025 Earnings Call Transcript
DocGo, Inc (NASDAQ:DCGO ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Mike Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Ryan MacDonald - Needham Kieran Ryan - Deutsche Bank Jenny Shen - BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all lines are in listen-only mode.
DocGo, Inc (DCGO) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates
DocGo Inc. (DCGO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.09 per share a year ago.
DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates
Neutral
Business Wire
1 month ago
DocGo Announces First Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, “The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populat.
DocGo Announces First Quarter 2025 Results
Neutral
Business Wire
1 month ago
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into DocGo Inc. (NasdaqCM: DCGO). DocGo is a healthcare company that provides medical transportation and mobile health services in the United States and the United Kingdom. In September 2023, news media sources reported numerous alleged misrepresentations by the Company, includin.
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
Neutral
Business Wire
1 month ago
DocGo to Announce First Quarter Results on Thursday, May 8, 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (.
DocGo to Announce First Quarter Results on Thursday, May 8, 2025
Neutral
PRNewsWire
1 month ago
DOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
NEW YORK and NEW ORLEANS , April 18, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
DOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO
Charts implemented using Lightweight Charts™